AJP - Cell Physiology, Vol 270, Issue 1 C40-C48, Copyright © 1996 by American Physiological Society

ARTICLES

Differential long-term regulation of MEK and of p42 MAPK in rat glomerular mesangial cells

H. Schramek, A. Sorokin, R. D. Watson and M. J. Dunn
Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Constitutive stimulation of the mitogen-activated protein kinase (MAPK) activator MAPK/ERK kinase (MEK) is sufficient to promote long-term events such as cell differentiation, proliferation, and transformation. To evaluate a possible mechanism for the chronic regulation of MEK and p42 MAPK, we studied the long-term effects of fetal bovine serum (FBS), the G protein-coupled receptor agonist endothelin-1 (ET-1), and the protein tyrosine kinase-coupled receptor agonist platelet-derived growth factor BB (PDGF BB) on MEK and p42 MAPK in glomerular mesangial cells (GMC). FBS, ET-1, and PDGF BB led to a time-dependent increase in MEK-1 mRNA and protein expression without altering p42 MAPK mRNA and protein levels. FBS also induced MEK-1 mRNA expression in diverse cell types, including NIH/3T3 fibroblasts, A7r5 vascular smooth muscle cells, and Chinese hamster ovary cells. In GMC, cycloheximide inhibited MEK-1 mRNA induction but stimulated p42 MAPK mRNA expression in the absence and presence of FBS, ET-1, or PDGF. The FBS-induced increase in MEK-1 mRNA was accompanied by a sustained enhancement of MEK activity, as assessed by the ability of immunoprecipitated p45 MEK to activate recombinant p42 MAPK and hence phosphorylate myelin basic protein, and p42 MAPK activity. We conclude that, in GMC, MEK-1 acts like a delayed-early gene and that it can be chronically induced at the mRNA and protein level.

This article has been cited by other articles:

				V. Pollack, R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1714 - F1726. [Abstract] [Full Text] [PDF]

				C. Grossmann, R. Freudinger, S. Mildenberger, A. W. Krug, and M. Gekle Evidence for epidermal growth factor receptor as negative-feedback control in aldosterone-induced Na+ reabsorption Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1226 - F1231. [Abstract] [Full Text] [PDF]

				H. Schramek MAP Kinases: From Intracellular Signals to Physiology and Disease Physiology, April 1, 2002; 17(2): 62 - 67. [Abstract] [Full Text] [PDF]

				D. BOKEMEYER, T. OSTENDORF, U. KUNTER, M. LINDEMANN, H. J. KRAMER, and J. FLOEGE Differential Activation of Mitogen-Activated Protein Kinases in Experimental Mesangioproliferative Glomerulonephritis J. Am. Soc. Nephrol., February 1, 2000; 11(2): 232 - 240. [Abstract] [Full Text] [PDF]

				N. Sugiura, T. Suga, Y. Ozeki, G. Mamiya, and K. Takishima The Mouse Extracellular Signal-regulated Kinase 2 Gene. GENE STRUCTURE AND CHARACTERIZATION OF THE PROMOTER J. Biol. Chem., August 22, 1997; 272(34): 21575 - 21581. [Abstract] [Full Text] [PDF]

				H. Schramek, E. Feifel, E. Healy, and V. Pollack Constitutively Active Mutant of the Mitogen-activated Protein Kinase Kinase MEK1 Induces Epithelial Dedifferentiation and Growth Inhibition in Madin-Darby Canine Kidney-C7 Cells J. Biol. Chem., April 25, 1997; 272(17): 11426 - 11433. [Abstract] [Full Text] [PDF]

				M. Gekle, R. Freudinger, S. Mildenberger, and S. Silbernagl Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells Am J Physiol Renal Physiol, April 1, 2002; 282(4): F669 - F679. [Abstract] [Full Text] [PDF]